CD4 and rheumatoid arthritis: Contradictorily, studies have shown that CTLA-4-Ig significantly increases the proportion of CD4+T and Treg cells by reducing the level of CD95 in the cells (175), but further analysis showed that Treg cell suppressive capacity and responsive T-cell proliferation ability were weakened in RA patients (176).